|
Exclusive license strengthens REQORSA gene therapy development for glioblastoma treatment. Promising preclinical data shows reduced tumor cell viability. Learn more.
|
|
|
New AI partnership introduces outcome-based enterprise solution for financial institutions. Promises 90-day implementation with military-grade security. See transformation details.
|
|
|
Q1 adjusted EPS hits $1.20 amid 12% inventory reduction. See how Helly Hansen acquisition shapes Kontoor's ambitious 19% revenue growth forecast. Get insights.
|
|
|
Leading SMR nuclear technology provider reveals extensive institutional investor outreach with six prestigious Wall Street conferences. See full schedule.
|
|
|
Energizer delivers 1.4% organic growth and margin expansion to 40.8%. Company navigates tariffs but warns of cautious consumer outlook. See updated guidance.
|
|
|
Ferrari's premium strategy delivers 23% profit jump and 30.3% margins. New model launches and personalization boost revenue to 1.79B. See full financial details.
|
|
|
Access Target Hospitality's live presentation at Oppenheimer's Industrial Conference. Key growth initiatives and market outlook to be discussed. Watch webcast here.
|
|
|
Q1 revenue reaches $17.8M with 13% growth and record 75.7% margins. Platform surpasses 2M genomic profiles. US business expands 30%. See full results.
|
|
|
Premium jeweler posts record Valentine's Day bookings, expands to 41 showrooms. See how shifting luxury consumer trends impacted Q1 margins and growth strategy.
|
|
|
TopBuild delivers 19% EBITDA margin despite revenue dip, returns $215.6M to shareholders. See how specialty distribution growth offsets installation decline.
|
|
Search Other Sites